Nondominant CD8 T Cells Are Active Players in the Vaccine-Induced Antitumor Immune Response-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Nondominant CD8 T Cells Are Active Players in the Vaccine-Induced Antitumor Immune Response

Published:2011-02-23 Issue:7 Volume:186 Page:3847-3857
ISSN:0022-1767
Container-title:The Journal of Immunology
language:en
Short-container-title:J.I.

Author:

Uram Jennifer N.,Black Chelsea M.,Flynn Emilee,Huang Lanqing,Armstrong Todd D.,Jaffee Elizabeth M.

Publisher

The American Association of Immunologists

Subject

Immunology,Immunology and Allergy

Reference66 articles.

1. Identification of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2-restricted tumor infiltrating lymphocytes.

2. Identification of an immunodominant peptide of HER-2/neu protooncogene recognized by ovarian tumor-specific cytotoxic T lymphocyte lines.

3. Immunodominance and Immunodomination: Critical Factors in Developing Effective CD8+ T‐Cell–Based Cancer Vaccines

4. Dominance and Crypticity of T Cell Antigenic Determinants

5. Confronting Complexity: Real-World Immunodominance in Antiviral CD8+ T Cell Responses

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Interrupting cyclic dinucleotide-cGAS–STING axis with small molecules;MedChemComm;2019

2. PD-1 Blockade Promotes Epitope Spreading in Anticancer CD8+T Cell Responses by Preventing Fratricidal Death of Subdominant Clones To Relieve Immunodomination;The Journal of Immunology;2017-09-22

3. A STING Agonist Given with OX40 Receptor and PD-L1 Modulators Primes Immunity and Reduces Tumor Growth in Tolerized Mice;Cancer Immunology Research;2017-05-08

4. Sorafenib combined with HER-2 targeted vaccination can promote effective T cell immunity in vivo;International Immunopharmacology;2017-05

5. Vaccines and Their Role in CD8 T Cell-Mediated Antitumor Immunity;Encyclopedia of Immunobiology;2016

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3